-+ 0.00%
-+ 0.00%
-+ 0.00%

BNP Paribas Exane Initiates Coverage On Astera Labs with Outperform Rating, Announces Price Target of $225

Benzinga·11/20/2025 12:39:29
Listen to the news
BNP Paribas Exane analyst Karl Ackerman initiates coverage on Astera Labs (NASDAQ:ALAB) with a Outperform rating and announces Price Target of $225.